NSE filing, NSE: SOTAC. Summary written from the filing by ALFA Finder's alert engine.
Sotac Pharmaceuticals Limited: key numbers
- Share price
- ₹111.65
- Market cap
- ₹123.4 Cr
- Revenue (annual)
- ₹101.2 Cr
- Net profit (annual)
- ₹6.29 Cr
- P/E (TTM)
- 19.6×Sector 45.9×
- Promoter holding
- 72.85%
- FII holding
- 16.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sotac Pharmaceuticals Limited
All →Sotac Pharmaceuticals Annual General Meeting
Sotac's EGM sought shareholder approval to raise authorised share capital from Rs.11.5 crore to Rs.15 crore. The video-conference meeting had one resolution.
Sotac Pharmaceuticals Annual General Meeting
Sotac Pharmaceuticals will hold an Extraordinary General Meeting on October 31, 2026, to seek shareholder approval for an increase in the company's authorised share capital.
Sotac Pharmaceuticals Capital Structure Change
Sotac Pharmaceuticals approved increasing its authorized share capital to Rs. 15 Crore. An Extra-Ordinary General Meeting will be convened to seek shareholder approval for this change.
Sotac Pharmaceuticals Dividend
Sotac Pharmaceuticals Limited has announced a record date of September 23, 2026, for the payment of a final dividend of Rs. 0.20 per share.
Sotac Pharmaceuticals Annual General Meeting
Sotac Pharmaceuticals Limited issued the notice for its 11th Annual General Meeting on September 30, 2026. Ordinary and special business will be transacted.
Sotac Pharmaceuticals Board Meeting Outcome
Sotac Pharmaceuticals' board approved the 11th AGM for September 30, 2026, and recommended a dividend of Rs. 0.20 per share.
Other other announcement announcements
All →Tata Chemicals Other Announcement
Tata Chemicals disclosed an ESG score of 68.74 from Niche Ninety Nine, an unengaged provider. The score uses public FY2025-26 data; no operational impact.
Usha Martin Other Announcement
Usha Martin disclosed a voluntary ESG rating of 69.57 assigned by Niche99, a SEBI-registered ESG Rating Provider, based on FY 2025-26 public data. The company did not engage the provider and the rating was not commissioned.
Robokidz Eduventures Other Announcement
Robokidz Eduventures filed its quarterly shareholding pattern for the period ended 30 September 2026. This is routine SEBI Regulation 31 disclosure with no transaction or corporate event.
Natco Pharma Other Announcement
Natco Pharma filed its shareholding pattern with a reporting date of 23 October 2026. Promoter and promoter group hold about 46% of total equity.
Innomet Advanced Materials Other Announcement
Innomet Advanced Materials filed its half-year Reg 32 statement on preferential issue proceeds, with no deviation. Rs.753.25 lakh raised in August 2026 was fully used for working capital.
CCME Global Other Announcement
CCME Global disclosed insider trades by two connected persons, acquiring 90 lakh and 22.5 lakh shares on 28 October 2026. Combined consideration is stated as Rs.112.50 Crore.
- Value
- ₹112.5 Cr